AGYS vs FORTY

AGYS exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational and financial stability, though the absence of an Altman Z-Score raises concern about bankruptcy risk assessment. The stock trades at a premium valuation with a current P/E of 64.01 and forward P/E of 31.50, significantly above the sector average of 77.74, suggesting high growth expectations are already priced in. Despite robust revenue and earnings growth (15.6% and 152.8% YoY respectively), the 6-month price decline of 35.3% and 1-month drop of 20.0% reflect strong bearish technical momentum. The Graham Number of $16.4 and intrinsic value of $31.57 suggest deep undervaluation, but the current price of $68.49 implies a substantial growth premium, making the stock vulnerable to downward revisions if growth slows.

FORTY exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 2/9, indicating deteriorating fundamental health. The stock is trading at a substantial premium, with a current price of $124.45 nearly double its Graham Number ($67.88) and Intrinsic Value ($67.85). While the company maintains a low Debt/Equity ratio, the unsustainable dividend payout ratio of 107.08% and a bearish technical trend (0/100) suggest a high risk of price correction. Extreme volatility in earnings growth and stagnant revenue growth (2.4% YoY) further undermine the current valuation.